Position in MRK
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$7,171,585
+$94,565 QoQ
Shares Held
55,810
-5.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#875
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. MRK ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
|
194,317 | $4,679,152 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,171,585 | 55,810 | Shares | Other | 2026-07-08 | |
| 2026-03-31 | $7,077,020 | 58,833 | Shares | Other | 2026-04-13 | |
| 2025-12-31 | $6,366,650 | 60,485 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $4,638,978 | 55,272 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $4,622,785 | 58,398 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $5,465,306 | 60,888 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $6,053,656 | 60,853 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $7,477,585 | 65,847 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $8,175,380 | 66,037 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $8,025,462 | 60,822 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $5,951,074 | 54,587 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $5,719,799 | 55,559 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $6,449,031 | 55,889 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $6,011,460 | 56,504 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $6,246,485 | 56,300 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $4,782,243 | 55,530 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $5,082,089 | 55,743 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $4,561,980 | 55,600 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $4,738,651 | 61,830 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $4,319,576 | 57,510 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $4,453,110 | 57,260 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $4,437,688 | 57,565 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $4,672,004 | 57,115 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $4,775,018 | 57,565 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $4,962,577 | 64,174 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $6,566,518 | 85,346 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||